Litigation Details for Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)
✉ Email this page to a colleague
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-07-16 |
Court | District Court, D. Delaware | Date Terminated | 2023-03-29 |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | None | Referred To | |
Patents | 10,065,952 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc.
Details for Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-07-16 | 1 | Complaint | civil action for patent infringement of U.S. Patent Nos. 10,065,952 (“the ’952 patent”), 10,844,058 (“…(“the ’058 patent”), 10,851,103 (“the ’103 patent”), 10,851,104 (“the ’104 patent”), 10,857,137 (“the…the ’137 patent”), 10,857,148 (“the ’148 patent”), 10,874,648 (“the ’648 patent”), 10,906,902 (“the ’902…’902 patent”), 10,906,903 (“the ’903 patent”), 10,912,771 (“the ’771 patent”), 10,919,892 (“the ’892 …892 patent”), 10,940,141 (“the ’141 patent”) and 10,952,997 (“the ’997 patent”) (collectively, “patents-in-suit | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |